Publicaciones en las que colabora con MANUEL PORTERO OTIN (14)

2022

  1. Human Atheromatous Plaques Expressed Sensing Adaptor STING, a Potential Role in Vascular Inflammation Pathogenesis

    Thrombosis and Haemostasis

  2. Ischemia preconditioning induces an adaptive response that defines a circulating metabolomic signature in ischemic stroke patients

    Journal of Cerebral Blood Flow and Metabolism, Vol. 42, Núm. 12, pp. 2201-2215

2021

  1. Acute ischemic stroke triggers a cellular senescence-associated secretory phenotype

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. REMOTE Ischemic Perconditioning Among Acute Ischemic Stroke Patients in Catalonia: REMOTE-CAT PROJECT

    Frontiers in Neurology, Vol. 11

2019

  1. Characteristics of atheromatosis in the prediabetes stage: A cross-sectional investigation of the ILERVAS project

    Cardiovascular Diabetology, Vol. 18, Núm. 1

  2. Lung function measurements in the prediabetes stage: data from the ILERVAS Project

    Acta Diabetologica, Vol. 56, Núm. 9, pp. 1005-1012

  3. Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project

    Diabetes and Metabolism

2018

  1. Metabolomic Estimation of the Diagnosis and Onset Time of Permanent and Transient Cerebral Ischemia

    Molecular Neurobiology, Vol. 55, Núm. 7, pp. 6193-6200

  2. Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors

    Medicina Clinica, Vol. 151, Núm. 10, pp. 383-389

2016

  1. Metabolomics Predicts Neuroimaging Characteristics of Transient Ischemic Attack Patients

    EBioMedicine, Vol. 14, pp. 131-138

  2. Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project

    Nefrologia, Vol. 36, Núm. 4, pp. 389-396

  3. Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 36, Núm. 4, pp. 389-396

2015

  1. Metabolomics predicts stroke recurrence after transient ischemic attack

    Neurology, Vol. 84, Núm. 1, pp. 36-45

2013

  1. Metabolomics in ischaemic stroke, new diagnostic and prognostic biomarkers

    Revista de Neurologia, Vol. 57, Núm. 1, pp. 29-36